Dobesil Calcium Hydrate 500mg

Adult dose

Adults: Administer the following doses of calcium dobesilate hydrate orally. 1. Vascular damage and retinopathy: 500~1000mg daily 2. Venous disease: Administer 750mg daily for 1~3 weeks, then administer 500mg daily. Administer after meals with plenty of fluid. Adjust the dose as appropriate according to age and symptoms.

This medication contains Dobesil Calcium Hydrate and should not be used by certain patients. Firstly, those who are allergic to this medication or any of its components should not use it. Women who are pregnant or breastfeeding should also avoid taking this medication. Additionally, as it contains lactose, individuals with issues regarding lactose digestion or genetic disorders such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should not take it. Patients with poor kidney function should use this medication with caution. Since this medication is primarily excreted through urine, dosage adjustments may be necessary for patients with renal failure. Particularly, patients with severe renal failure requiring dialysis should reduce the dosage as directed by their physician. Patients with liver dysfunction should also exercise caution when using this medication and reevaluate the treatment effect and risks if liver enzyme levels elevate. This medication contains sulfite, which can cause allergic reactions. Asthma patients may be particularly sensitive to sulfites, so caution is necessary. When taking this medication, gastrointestinal symptoms such as headache, abdominal pain, nausea, diarrhea, and vomiting are commonly observed. Joint pain or muscle ache may also be relatively frequent side effects. Allergic reactions such as skin rash, itching, and hives may rarely occur. Very rarely, serious side effects such as a decrease in blood cell count may occur, so if high fever or symptoms of infection arise, consult a physician immediately. If any unusual symptoms occur while taking this medication, stop treatment immediately and inform medical personnel. Also, this medication may affect blood test results, so consultation and testing before administration is necessary. No special interactions with other medications are known, but it is always advisable to consult a physician or pharmacist.

• Agranulocytosis
• neutropenia
• leukopenia
• skin rash
• allergic dermatitis
• itching
• hives
• facial swelling
• anaphylactic reaction
• headache

This medication should be stored in a tightly sealed container that blocks light and kept at room temperature between 1 to 30 degrees Celsius. Storing it in this manner can help maintain its effectiveness and prevent deterioration.

Appearance

White oblong tablet

Package unit

30 tablets/bottle, 90 tablets/bottle